Skip to main content
$116.18 $1.78 (1.6%)

04:00 PM EDT on 03/31/23

Dexcom Inc (NASDAQ:DXCM)

CAPS Rating: 4 out of 5

A medical device company focused on the design, development and commercialization of continuous glucose monitoring systems for people with diabetes.

Current Price $116.18 Mkt Cap $44.9B
Open $115.02 P/E Ratio 230.40
Prev. Close $116.18 Div. (Yield) $0.00 (0.0%)
Daily Range $114.52 - $116.87 Volume 2,118,213
52-Wk Range $66.89 - $134.77 Avg. Daily Vol. 2,475,367

Caps

How do you think NASDAQ:DXCM will perform against the market?

Add Stock to CAPS Watchlist

All Players

336 Outperform
97 Underperform
 

All-Star Players

53 Outperform
16 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:DXCM Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

lemiwinx (32.58)
Submitted August 02, 2022

Best diabetes stock. Best in class devices for monitoring diabetes.

TMFjimhalley (< 20)
Submitted November 13, 2020

The company is having a great year, but based on its price-to-earnings ratio and its PEG, it's still a bit overpriced compared to its peers.

Recent Community Commentary

Read the most recent pitches from players about DXCM.

Recs

1
Member Avatar lemiwinx (32.58) Submitted: 8/2/2022 10:15:52 AM : Outperform Start Price: $86.82 NASDAQ:DXCM Score: +34.49

Best diabetes stock. Best in class devices for monitoring diabetes.

Recs

1
Member Avatar DZBV216 (< 20) Submitted: 6/13/2022 10:22:35 AM : Outperform Start Price: $70.15 NASDAQ:DXCM Score: +57.46

Trust in Nick Sciple

Recs

1
Member Avatar dpfriedman (39.10) Submitted: 1/28/2022 3:42:07 PM : Outperform Start Price: $102.41 NASDAQ:DXCM Score: +20.54

Leader of the space for testing Diabetes and Americans are getting fatter everyday.

Leaderboard

Find the members with the highest scoring picks in DXCM.

Score Leader

ardys13

ardys13 (< 20) Score: +12,093.77

The Score Leader is the player with the highest score across all their picks in DXCM.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
ardys13 < 20 2/9/2009 Outperform 1Y $0.93 +12,469.73% +375.96% +12,093.77 1 Comment
bigrick22 < 20 3/24/2008 Outperform NS $1.00 +11,527.00% +217.67% +11,309.33 0 Comment
CleverKat 67.20 3/24/2008 Outperform NS $1.07 +10,791.80% +214.20% +10,577.60 0 Comment
cpalerm 93.03 3/23/2009 3/13/2014 Outperform 5Y $1.08 +10,665.74% +424.04% +10,241.70 1 Comment
MEGIN7790 < 20 4/4/2008 Outperform NS $1.11 +10,351.24% +208.17% +10,143.07 0 Comment
LazyTimeMoney 72.84 4/7/2008 Outperform NS $1.26 +9,127.78% +207.65% +8,920.13 0 Comment
jabrink 78.48 4/7/2008 Outperform 3W $1.27 +9,073.18% +207.40% +8,865.77 0 Comment
GriffinRex 90.65 4/8/2008 Outperform 3M $1.29 +8,895.74% +210.85% +8,684.90 0 Comment
cash4metoo 63.50 5/28/2009 Outperform 1Y $1.34 +8,609.36% +356.14% +8,253.22 0 Comment
YahooSIRIous 93.32 7/13/2009 Outperform 5Y $1.34 +8,593.08% +364.63% +8,228.45 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for DXCM.